The downgrade by Citigroup from Buy to Neutral suggests a less optimistic outlook on Albemarle's future performance. Additionally, the significant reduction in the price target from $175 to $120 indicates a lowered expectation of the stock's value, which could lead to a negative short-term impact on its stock price.